CoCliP-BJI study: cost avoidance of clinical pharmacist-led interventions in patients with bone and joint infections.
| dc.rights.license | open | en_US |
| dc.contributor.author | COUVÉ, Eloïse | |
| hal.structure.identifier | Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases | |
| dc.contributor.author | LAHOUATI, Marin | |
| dc.contributor.author | LEITAO, Julie | |
| dc.contributor.author | MEIRELES, Vasco Dias | |
| dc.contributor.author | DAUCHY, Frederic | |
| hal.structure.identifier | Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases | |
| dc.contributor.author | XUEREB, Fabien | |
| dc.date.accessioned | 2025-06-02T07:54:03Z | |
| dc.date.available | 2025-06-02T07:54:03Z | |
| dc.date.issued | 2025-05-28 | |
| dc.identifier.issn | 2666-9919 | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/206805 | |
| dc.description.abstractEn | Patients with bone and joint infections (BJI) are part of a complex care pathway. This study aimed to evaluate the economic impact of clinical pharmacist-led interventions in the management of BJI patients. We performed a retrospective study documenting all pharmacist-led interventions (PI). Their impact was assessed using the clinical economic and organizational scale (CLEO SFPC). The probability of adverse drug events (ADE) in the absence of PI was assessed by a panel of three experts. Cost avoidance was calculated for PIs with major clinical impact using a cost of €5,331 per event, multiplied by the probability of ADE occurrence. A total of 41 PIs had a major clinical impact. Cost avoidance associated with the intervention of a pharmacist was estimated at €83,750.01 during the study. The implementation of pharmacist-led interventions in the management of patients with BJI helps avoid preventable healthcare costs. | |
| dc.language.iso | EN | en_US |
| dc.subject.en | Adverse events; Antibiotics; Bone and joint infection; Clinical pharmacy; Medication safety. | |
| dc.title.en | CoCliP-BJI study: cost avoidance of clinical pharmacist-led interventions in patients with bone and joint infections. | |
| dc.title.alternative | Infect Dis Now | en_US |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.1016/j.idnow.2025.105104 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Médecine humaine et pathologie | en_US |
| dc.identifier.pubmed | 40447052 | en_US |
| bordeaux.journal | Infectious Diseases Now | en_US |
| bordeaux.page | 105104 | en_US |
| bordeaux.hal.laboratories | Biologie des maladies cardiovasculaires (BMC) - UMR 1034 | en_US |
| bordeaux.institution | Université de Bordeaux | en_US |
| bordeaux.institution | INSERM | en_US |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | non | en_US |
| bordeaux.import.source | pubmed | |
| hal.identifier | hal-05092497 | |
| hal.version | 1 | |
| hal.date.transferred | 2025-06-02T07:54:07Z | |
| hal.popular | non | en_US |
| hal.audience | Internationale | en_US |
| hal.export | true | |
| workflow.import.source | pubmed | |
| dc.rights.cc | Pas de Licence CC | en_US |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Infectious%20Diseases%20Now&rft.date=2025-05-28&rft.spage=105104&rft.epage=105104&rft.eissn=2666-9919&rft.issn=2666-9919&rft.au=COUV%C3%89,%20Elo%C3%AFse&LAHOUATI,%20Marin&LEITAO,%20Julie&MEIRELES,%20Vasco%20Dias&DAUCHY,%20Frederic&rft.genre=article |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||